STAT

DECEMBER 28, 2023

STAT’s taking a look at some of the recent health policy trends that states will start to implement in 2024. For most states, the new year means a new legislative session.

Drug Pricing 259

Drug Pricing Hospitals 259

STAT

APRIL 1, 2025

In 2024, total U.S. spending on prescription drugs was almost $800 billion. Although low-cost generic drugs filled 91% of all prescriptions, the 9% of prescriptions filled with a branded medicine accounted for 84% of drug spending.

Prescription Filling 186

Prescription Filling Drug Pricing Drug Development 186

Drug Channels

APRIL 4, 2025

It's time for Drug Channels annual examination of U.S. brand-name drug pricing. For 2024, average brand-name drugs list prices grew by only 2.3%. Whats more, after adjusting for overall inflation, brand-name drug net prices dropped for an unprecedented seventh consecutive year.

Drug Pricing 52

Drug Pricing 52

STAT

JULY 15, 2024

In April, the lawmakers wrote to the company expressing alarm at its decision, announced in November, that it would permanently discontinue Levemir by the end of 2024. Novo Nordisk will meet with aides for senators Jeanne Shaheen, Raphael Warnock, and Elizabeth Warren.

Drug Pricing 210

Drug Pricing Biosimilars Diabetes 210

STAT

JULY 27, 2023

And of course, do keep in touch… Call it drug pricing déjà vu: Just as they did in 2019, House Democrats are pushing a bill that would allow Medicare to negotiate dozens of drug prices a year, offer those prices to all insurers, and crack down on price hikes , STAT says.

Drug Pricing 233

Drug Pricing 233

STAT

FEBRUARY 15, 2024

The pharmaceutical industry, in court and in Congress, is working to water down legislation that will let Medicare negotiate certain drug prices. STAT Washington correspondent Rachel Cohrs joins us to explain the industry’s struggle to make headway — and how it factors into the 2024 election.

Drug Pricing 232

Drug Pricing 232

STAT

AUGUST 10, 2023

By doing so, the company would sell more medicines in the window before Medicare is allowed to negotiate prices, because the clock for when discounts can kick in is based on when the drug first goes on the market. Novo Nordisk will continue to restrict U.S. demand , STAT notes. The

Drug Pricing 210

Drug Pricing Diabetes 210

Drug Channels

APRIL 5, 2024

Thanks to the IRA, Part D Plans Will Prefer High-List, High-Rebate Drugs. Click here to see the original post from January 2024. It's time for Drug Channels ’ annual reality check on U.S. drug pricing. For 2023, brand-name drugs’ list prices again grew at mid-single-digit rates.

Drug Pricing 94

Drug Pricing 94

STAT

JULY 23, 2024

Medicare and Medicaid are facing a familiar quandary: how to provide coverage for new weight loss drugs with price tags that could effectively bankrupt the federal government’s health care budget while simultaneously ensuring continuous coverage for all other health care services used by millions of Americans.

Drug Pricing 357

Drug Pricing 357

Drug Channels

FEBRUARY 27, 2024

In this issue: An update on the retail pharmacy shakeout Arguing for high drug prices A leading researcher provides a 340B reality check Physicians don’t want pharmacists getting uppity Plus, Dave Grohl fights for your right to…have healthcare price transparency? Sorry, no Threads.) All rights reserved.

Drug Pricing 95

Drug Pricing 95

STAT

JANUARY 11, 2024

JPM Week is finally drawing to a close, sending the drug industry’s many financiers scattering from San Francisco to their respective homes and ski destinations. In honor of JPM Week, you’re reading a special edition of our biotech newsletter, The Readout.

Drug Pricing 254

Drug Pricing Drug Development 254

European Pharmaceutical Review

JANUARY 2, 2024

According to results from a survey by GlobalData, the top challenges for the pharmaceutical industry in 2024 will be inflation, geopolitical conflict and drug pricing pressures. Data outcomes revealed that most respondents from Pharma considered that drug pricing and reimbursement constraints will have a negative impact in 2024.

Drug Pricing 102

Drug Pricing Drug Development 102

STAT

DECEMBER 27, 2023

As another year comes to an end and the world seems to hit the proverbial pause button, the temptation to look ahead is too great to ignore. After all, this is what journalists like to do as the calendar turns another page. So once again, we will take a whack at identifying some of the most noteworthy developments to watch.

Drug Pricing 234

Drug Pricing 234

Drug Channels

JANUARY 3, 2024

It's time for Drug Channels ’ annual reality check on U.S. drug pricing. For 2023, brand-name drugs’ list prices again grew at mid-single-digit rates. However, net prices dropped for an unprecedented sixth consecutive year. Details below.

Drug Pricing 97

Drug Pricing 97

BioPharma Dive

JANUARY 10, 2024

In the background, a contentious drug pricing law looms. Many drugmakers hope to compete in obesity, while others seek to win oncology’s next era.

Drug Pricing 119

Drug Pricing 119

Safe Biologics

FEBRUARY 1, 2024

Comments may be submitted here until April 30, 2024. UPCOMING EVENTS WHO 78th INN Consultation Geneva, Switzerland – March 19, 2024 ASCO Annual Meeting Chicago, IL – May 31-June 4, 2024 BIO International Meeting San Diego, CA – June 3-6, 2024 DIA Global Annual Meeting San Diego, CA – June 16-20, 2024

Biosimilars 130

Biosimilars Documentation Drug Pricing 130

STAT

OCTOBER 18, 2024

As Election Day 2024 gets closer, STAT’s First Opinion asked executives from leading biotech and pharmaceutical companies to reflect on how their industry is being portrayed in the presidential campaign — and what their hopes are for a new presidential administration. You

Pharmaceutical Companies 231

Pharmaceutical Companies Pharmaceutical Companies Drug Pricing 231

Express Pharma

NOVEMBER 28, 2024

The report was launched at the OPPI Annual Summit 2024 with the theme: Viksit Bharat @2047 – Transforming India from Pharmacy of the World to Pharma Powerhouse to the World -a summit with the attendance of industry leaders, innovators, scientists and government officials.

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies Drug Pricing 105

STAT

MARCH 3, 2023

… Now that Eli Lilly slashed the price for some of its insulin products, the moves raised questions about what will happen to other efforts to provide low-cost insulin, Kaiser Health News explains. And the Mark Cuban Cost Plus Drug Co. But drug=pricing experts predict Lilly’s moves will not undercut those efforts.

Drug Pricing 221

Drug Pricing Biosimilars 221

Drug Channels

MARCH 19, 2024

I am pleased to announce our new 2024 Economic Report on U.S. Download a free report overview (including key industry trends, the Table of Contents, and a List of Exhibits) HMP Global’s Drug Channels Institute releases ‘2024 Economic Report on U.S. The 2024 Economic Report on U.S. Read on for some additional details.

Drug Pricing 96

Drug Pricing 96

Drug Channels

MARCH 7, 2024

On March 19, 2024, Drug Channels Institute will release The 2024 Economic Report on U.S. drug pricing, reimbursement, and dispensing system. prescription drug channels. prescription drug channels. Review pricing/license options and place a preorder. Pharmacies and Pharmacy Benefit Managers.

Drug Pricing 98

Drug Pricing 98

Drug Channels

DECEMBER 5, 2023

The common factor behind these two disparate situations: Pharmaceutical wholesalers’ unusual pricing for brand-name drugs sold to pharmacies, hospitals, and other buyers. Below, I walk through the economic fundamentals to help you understand another obscure aspect of our opaque drug pricing system. to 1:30 p.m.

Drug Pricing 98

Drug Pricing Hospitals 98

STAT

JANUARY 4, 2024

Damian here with an in-depth preview of a certain annual biotech conference, a look at the cutting edge of obesity drug development, and year’s first IPO filing. Want to stay on top of the science and politics driving biotech today?    Sign up  to get our biotech newsletter in your inbox. Good morning, everyone.

Drug Development 201

Drug Development Drug Pricing 201

Drug Channels

NOVEMBER 14, 2023

Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for DCI’s new live video webinar: Drug Channels Outlook 2024 This event will be broadcast live on Friday, December 15, 2023 12:00 p.m. This event is part of The Drug Channels 2023 Video Webinar Series. Dr. Adam J.

Drug Pricing 98

Drug Pricing Biosimilars 98

STAT

MARCH 14, 2023

list prices for several insulin products by up to 75%, the latest big drugmaker to take such a step in response to a years-long outcry over the cost of the diabetes treatments. The company plans to cut the list price of its NovoLog insulin by 75%, and the prices for Novolin and Levemir by 65% starting in January 2024.

Diabetes 246

Diabetes Drug Pricing 246

STAT

MARCH 16, 2023

Following the lead of its rivals, Sanofi will cut the price of its most widely prescribed insulin in the U.S. The change comes after Eli Lilly and then Novo Nordisk announced plans this month to reduce list prices for some of their own insulin products by similar amounts. The moves will go into effect on Jan.

Drug Pricing 246

Drug Pricing 246

STAT

NOVEMBER 11, 2024

million in the first three quarters of 2024, compared with $3.63  The pharmaceutical industry is poised for an opportunity to tweak parts of the Medicare drug pricing negotiation law, after Republicans took control of the White House and Senate. GSK has spent slightly more on lobbying this year compared with 2023.

Drug Pricing 219

Drug Pricing 219

Drug Channels

JULY 12, 2024

Gavin discusses the three key reasons for duplicate discounts between the 340B Drug Pricing Program and the Medicaid Drug Rebate Program. To learn more, register for Kalderos’ August 21, 2024, webinar: Revolutionizing Government Discount Programs: Why Traditional Methods Fail. Read on for Gavin’s insights.

Drug Pricing 98

Drug Pricing 98

Digital Pharmacist

APRIL 25, 2023

f you’re an independent pharmacy owner or pharmacist, you’re probably aware of the upcoming changes to DIR fees that will take effect in 2024. In this blog post, we will discuss the evolution of DIR fees leading up to the DIR fee changes coming in 2024, and the pros and cons independent pharmacies owners should prepare for.

Independent Pharmacies 98

Independent Pharmacies Drug Utilization Review Drug Pricing Pharmacy Management 98

STAT

JULY 31, 2023

Hospitals band together to negotiate drug prices, and makers of generic injectables say those group purchasing organizations can drive prices down so low that they stop making certain drugs or cannot afford to maintain manufacturing facilities, which then leads to manufacturing interruptions.

Hospitals 194

Hospitals Drug Pricing Chemotherapy 194

Drug Channels

DECEMBER 3, 2024

Minnesota just released the industry‘s first ever mandated financial report on the 340B Drug Pricing Program. During next week’s Drug Channels Outlook 2025 live video webinar, he'll tell you what's ahead for the program that continues to defy gravity. It’s time to pay attention to the money behind the 340B curtain.

Drug Pricing 52

Drug Pricing Hospitals 52

Express Pharma

APRIL 8, 2025

Licensing agreements for Chinese drug candidates hit a record high in 2024, with large pharma in-licensing 28 per cent of innovator drugs from Chinese biopharma companies. Total deal values of innovator drug licensing agreements involving Chinese biopharma licensors surged 66 per cent, from $16.6 billion in 2024.

Drug Pricing 66

Drug Pricing 66

STAT

AUGUST 22, 2023

WASHINGTON — David Ricks, who leads Eli Lilly, made a major early donation to a super PAC in support of former vice president Mike Pence — one of the first big 2024 donations from a major player in the pharmaceutical industry.

Drug Pricing 239

Drug Pricing 239

Drug Channels

MARCH 12, 2024

Next week, Drug Channels Institute (DCI) will release our 2024 Economic Report on U.S. drug pricing, reimbursement, and dispensing system. We’re offering special discounted pricing if you order before April 7, 2024. Pharmacies and Pharmacy Benefit Managers. For 2023, DCI estimates that U.S. to 1:30 p.m.

Drug Pricing 98

Drug Pricing 98

Drug Channels

APRIL 2, 2025

Click here to see the original post from December 2024. Minnesota just released the industrys first ever mandated financial report on the 340B Drug Pricing Program. This week, Im rerunning some popular posts while I prepare for Fridays live video webinar: PBM Industry Update: Trends, Challenges, and Whats Ahead.

Drug Pricing 52

Drug Pricing Hospitals 52

Drug Channels

FEBRUARY 7, 2024

And contrary to what you might read, drug spending growth was *not* driven by purportedly “skyrocketing” drug prices. In reality, nearly all drug spending growth occurred due to growth in the number of people treated, prescriptions dispensed, and other nonprice factors. healthcare expenditures. healthcare expenditures.

Drug Pricing 98

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies 98

Drug Channels

MAY 21, 2024

Fein, president of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for DCI’s new live video webinar: The 340B Drug Pricing Program: Trends, Controversies, and Outlook This event will be broadcast live on Friday, June 21, 2024, from 12:00 p.m. to 1:30 p.m. All rights reserved.

Drug Pricing 52

Drug Pricing 52